MYC and cancer: Hyperactivation of MYC occurs in 60–70% of all human cancers, and MYC is classified as a major cancer driver (Dang, 2012; Gabay et al., 2014; Nesbit et al., 1999; Stefan and Bister, 2017; Stine et al., 2015; Tokheim et al., 2016).